The start of the year is a good time to add to your existing portfolio or start new positions. An excellent source to look for stock ideas is the Dogs of the Dow. These stocks are the highest-yielding ones in the Dow Jones Industrial Average (DJIA) at the end of the preceding year.
The strategy assumes the stocks are temporarily mispriced, and thus the yields are high. Additionally, the Dogs of the Dow are blue-chip stocks with sustainable growth and excellent reputations. Hence, they make good picks for income investors.
We emphasize dividend yield, conservative payout ratio, and valuation in our five picks. These five stocks make great choices for investors seeking higher yields at a reasonable price to generate dividend income.
The Sure Dividend Newsletter for high-quality dividend growth stocks.
- The monthly newsletter includes stock analyses, portfolio ideas, dividend risk scores, real money portfolio, etc.
- Risk free 7-day free trial and $41 off only through Dividend Power for $158 per year.
- Sure Dividend Coupon Code – DP41
Click here to try the Sure Dividend Newsletter (7-day free trial).
5 Dogs of the Dow Stocks 2023 for Income Investors
Verizon Communications (VZ) continues to be a consistent theme in our selection because of the combination of nearly a decade-high dividend yield and significant undervaluation. Few stocks offer both at the same time.
For most of 2022, Verizon was challenged with growing its retail cellular subscribers. But a recent statement by the Chief Executive Officer (CEO) suggests the trend may have reversed in 2023. Also, the firm is reducing capital spending and cutting expenses. This is good news, and investors bid up the stock price off its lows in response.
Still, the stock is yielding more than 6.5%, well above the 5-year average and more than three times the dividend yield of the S&P 500 Index. Verizon increases the dividend by about 2% annually and has done so for the past 19 years. The dividend is supported by a payout ratio of only about 49%.
Verizon is dirt cheap, trading at a price-to-earnings ratio of only ~7.7X, well below the 5-year and 10-year ranges. As a result, Verizon is an excellent choice for investors seeking income at a reasonable price.
Related Articles About Verizon (VZ) on Dividend Power
Walgreens Boots Alliance
Walgreens Boots Alliance (WBA), the second stock on this list, has been on the Dogs of the Dow annually since 2020 because of its recurring high dividend yield. The pharmacy retailer has struggled with low growth, opioid lawsuits, and more competition. In addition, the 2015 merger between Walgreens and Boots Alliance caused difficulties.
That said, a new CEO is seemingly executing better. She also has a vision for expanding into healthcare. Along these lines, VillageMD recently acquired Summit Health for primary care, the firm acquired Shields for specialty care and has CareCentrix for post-acute care. Whether this strategy will work or not, though, will take time to determine.
In the meantime, investors are paid to wait with a roughly 5.4% yield supported by a ~42% payout ratio. Walgreens is not far from entering Dividend King status with 47 years of increases, but the dividend increase rate has slowed.
Walgreens is trading at a low earnings multiple of ~7.9X, below the 5-year and 10-year ranges. However, despite the near-term difficulties, the company is consistently profitable.
Related Articles About Walgreens Boots Alliance (WBA) on Dividend Power
Intel Corporation (INTC) is having one of its worst stretches since the dot-com boom and crash between the company’s missteps and a changing competitive environment. The company has faced difficulties shrinking its fabrication lines to 7nm and 4nm, causing them to fall behind Taiwan Semiconductor (TSM).
Next, the ARM-based chips produced by Advanced Micro Devices are eating into Intel’s PC and server market share. Intel designs and manufactures its own chips, while AMD designs and outsources manufacturing to TSMC. Lastly, clients are increasingly developing their own chips and outsourcing manufacturing to fabs like TSMC or Samsung.
The result has been shareholders selling Intel stock, and the stock price has dropped to levels last seen in 2014 to 2015. Simultaneously, the dividend yield has soared to more than 5%.
That said, Intel introduced Sapphire Rapids in its Xeon series of chips for data centers. Next, Intel’s impending launch of Intel 4, 7nm fabrication will make the firm’s chips more competitive versus AMD’s chips. Finally, Intel is spending tens of billions of dollars to expand its fab services with new plants in Arizona and Ohio.
Intel’s turnaround is still in the early stages, and the market hates the company, but the high demand for chips should be a tailwind. The highest yield in a decade with the potential for recovery make Intel an intriguing choice. That said, the risk of a dividend cut or freeze is now higher.
Related Articles About Intel (INTC) on Dividend Power
International Business Machines
International Business Machines (IBM) is another company investors love to hate. But the firm performed better than its peers in 2022, and momentum may continue into 2023. IBM started its turnaround in 2019 with the acquisition of Red Hat, moving definitively into hybrid cloud. Subsequently, a new CEO, followed by separating the managed infrastructure business into Kyndryl (KD), has refocused the company.
Today, IBM is about software, consulting, and mainframes. The firm is a leader in mainframes, hybrid cloud, transaction processing, and global consulting. That said, IBM has room to improve revenue growth and margins.
The dividend yield of ~4.7% is amongst the highest of the Dividend Aristocrats, making IBM attractive. The firm is committed to the dividend and is one of the longest paying dividend stocks. Also, although the current raises are meager, IBM raises the dividend annually. IBM is undervalued compared to its peers based on the P/E ratio.
Related Articles About IBM on Dividend Power
The fifth Dow stock is Amgen (AMGN). Amgen’s stock price continues to trend up after some weakness during the COVID-19 pandemic. The firm has several blockbuster drugs with billions of dollars in sales. But investors were worried about patent expirations and rising competition from biosimilars.
The company has dealt with challenges to its product portfolio by acquiring the oral immunology drug Otzela to complement Enebrel. Moreover, Amgen has pursued a strategy of acquiring smaller companies and gaining access to new molecules, compounds, and therapies. Since 2021, Amgen has acquired ChemoCentryx, Tenebio, and FivePrime Therapeutics in multi-billion-dollar deals.
Recently, Amgen announced the nearly $28 billion cash and debt deal for Horizon Therapeutics, growing the portfolio with the Tepezza blockbuster drug, several others with sales, and a robust pipeline.
Amgen is yielding 3.2%, and the dividend is growing at a double-digit rate. Future growth is supported by a moderate payout ratio of 42%. The stock is probably fairly valued, but a successful acquisition of Horizon could mean future growth.
Related Articles About Amgen (AMGN) on Dividend Power
Disclosure: Long VZ, IBM, AMGN
A version of this post by Dividend Power originally appeared in Investor Place and was republished with permission.
Related Articles on Dividend Power
Here are my recommendations:
- Simply Investing Report & Analysis Platform or the Course can teach you how to invest in stocks. Try it free for 14 days.
- Sure Dividend Newsletter is an excellent resource for DIY dividend growth investors and retirees. Try it free for 7 days.
- Stock Rover is the leading investment research platform with all the fundamental metrics, screens, and analysis tools you need. Try it free for 14 days.
- Portfolio Insight is the newest and most complete portfolio management tool with built-in stock screeners. Try it free for 14 days.
Receive a free e-book, “Become a Better Investor: 5 Fundamental Metrics to Know!” Join thousands of other readers !
*This post contains affiliate links meaning that I earn a commission for any purchases that you make at the Affiliates website through these links. This will not incur additional costs for you. Please read my disclosure for more information.
Prakash Kolli is the founder of the Dividend Power site. He is a self-taught investor, analyst, and writer on dividend growth stocks and financial independence. His writings can be found on Seeking Alpha, InvestorPlace, Business Insider, Nasdaq, TalkMarkets, ValueWalk, The Money Show, Forbes, Yahoo Finance, and leading financial sites. In addition, he is part of the Portfolio Insight and Sure Dividend teams. He was recently in the top 1.0% and 100 (73 out of over 13,450) financial bloggers, as tracked by TipRanks (an independent analyst tracking site) for his articles on Seeking Alpha.